These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23748418)

  • 1. [Fentanyl: fast and furious?].
    Meissner W; Sabatowski R
    Anaesthesist; 2013 Jun; 62(6):429-30. PubMed ID: 23748418
    [No Abstract]   [Full Text] [Related]  

  • 2. Fentanyl pectin nasal spray for breakthrough cancer pain.
    Taylor DR; Gabrail N
    Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral formulations of fentanyl for breakthrough cancer pain.
    Handsaker S; Dempsey L; Fabby C
    Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588
    [No Abstract]   [Full Text] [Related]  

  • 4. Fentanyl for breakthrough pain: a systematic review.
    Davis MP
    Expert Rev Neurother; 2011 Aug; 11(8):1197-216. PubMed ID: 21797660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl pectin nasal spray for breakthrough cancer pain.
    Torres LM; Trinidad JM; Calderón E; Benitez D; Perelman M
    Int J Palliat Nurs; 2015 Mar; 21(3):114-6. PubMed ID: 25815759
    [No Abstract]   [Full Text] [Related]  

  • 6. Fentanyl sublingual tablets. Breakthrough pain: new formulation, no therapeutic advantage.
    Prescrire Int; 2010 Feb; 19(105):16. PubMed ID: 20455334
    [No Abstract]   [Full Text] [Related]  

  • 7. WITHDRAWN: Opioids for the management of breakthrough pain in cancer patients.
    Zeppetella G; Davies AN
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD004311. PubMed ID: 26275024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Gombert-Handoko KB
    Clin Ther; 2014 Nov; 36(11):1704. PubMed ID: 25048312
    [No Abstract]   [Full Text] [Related]  

  • 9. Fast-acting fentanyl preparations and pain management.
    McWilliams K; Fallon M
    QJM; 2013 Oct; 106(10):887-90. PubMed ID: 23613597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design for breakthrough pain: is it ethical to have a placebo in a trial?
    Davis MP; Bruera E
    Clin Ther; 2014 May; 36(5):814-5. PubMed ID: 24726089
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial design for breakthrough pain: is it ethical to have a placebo in a trial? Author reply.
    Trinquet F
    Clin Ther; 2014 May; 36(5):816. PubMed ID: 24726087
    [No Abstract]   [Full Text] [Related]  

  • 12. Are there cost benefits to fentanyl for breakthrough pain?
    Davis MP
    J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
    Núñez-Olarte JM; Alvarez-Jiménez P
    J Pain Symptom Manage; 2011 Dec; 42(6):e6-8. PubMed ID: 22048003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Breakthrough pain and short-acting opioids].
    Beutlhauser T; Oeltjenbruns J; Schäfer M
    Anaesthesist; 2013 Jun; 62(6):431-9. PubMed ID: 23754483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of breakthrough cancer pain].
    Sláma O
    Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer breakthrough pain. Indications for rapidly effective opioids].
    Kessler J; Bardenheuer HJ
    Anaesthesist; 2011 Jul; 60(7):674-82. PubMed ID: 21491140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care.
    Chang A; Roeland EJ; Atayee RS; Revta C; Ma JD
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):247-60. PubMed ID: 26368648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction with intranasal fentanyl for breakthrough pain.
    Veldhorst-Janssen NM; Fiddelers AA; Zandstra H; Kessels AG; Zandstra H; Marcus MA; Neef C; van der Kuy PH
    J Palliat Med; 2012 Jun; 15(6):631-2. PubMed ID: 22656053
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.
    Hair PI; Keating GM; McKeage K
    Drugs; 2008; 68(14):2001-9. PubMed ID: 18778121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of adult breakthrough cancer pain.
    Doulton B
    Can Fam Physician; 2014 Dec; 60(12):1111-4, e585-9. PubMed ID: 25500600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.